Article 6G9Y1 Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial

Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial

by
Emily Mullin
from Feed: All Latest on (#6G9Y1)
Story ImageThe drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths.
External Content
Source RSS or Atom Feed
Feed Location http://feeds.wired.com/wired/index
Feed Title Feed: All Latest
Feed Link https://www.wired.com/
Feed Copyright © Condé Nast 2024
Reply 0 comments